The Current Ratio as of December 2025 (TTM) for Wuhan General Group (China), Inc. (WUHN) is 3.18

According to Wuhan General Group (China), Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.18. This represents a change of 353.06% compared to the average of 0.70 of the last 4 quarters.

Wuhan General Group (China), Inc. (WUHN) Historical Current Ratio (quarterly & annually)

How has WUHN Current Ratio performed in the past?

The mean historical Current Ratio of Wuhan General Group (China), Inc. over the last ten years is 3.55. The current 3.18 Current Ratio has changed 8.88% with respect to the historical average. Over the past ten years (40 quarters), WUHN's Current Ratio was at its highest in in the June 2022 quarter at 1.38. The Current Ratio was at its lowest in in the September 2022 quarter at 0.03.

Wuhan General Group (China), Inc. (WUHN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Wuhan General Group (China), Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Wuhan General Group (China), Inc. (WUHN) Average Current Ratio

How has WUHN Current Ratio performed in the past?

The current Current Ratio of Wuhan General Group (China), Inc. (WUHN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Wuhan General Group (China), Inc. (WUHN) Current Ratio vs. Peers

How is WUHN’s Current Ratio compared to its peers?

Wuhan General Group (China), Inc.’s Current Ratio is greater than Upper Street Marketing Inc. (0.79), greater than MJ Holdings, Inc. (0.39), greater than Aida Pharmaceuticals, Inc. (0.93), less than Panacos Pharmaceuticals, Inc. (5.47), greater than CEN Biotech, Inc. (0.03), greater than Bloomios, Inc. (0.09), greater than Oncology Pharma Inc. (0.00), greater than InnerScope Hearing Technologies, Inc. (1.03), greater than Emergent Health Corp (0.04), greater than Arno Therapeutics, Inc. (0.08),

Build a custom stock screener for Wuhan General Group (China), Inc. (WUHN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wuhan General Group (China), Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wuhan General Group (China), Inc. (WUHN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wuhan General Group (China), Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.